MOLECULAR DETERMINANTS OF AMYLOID DEPOSITION IN ALZHEIMERS-DISEASE - CONFORMATIONAL STUDIES OF SYNTHETIC BETA-PROTEIN FRAGMENTS

被引:311
作者
HALVERSON, K
FRASER, PE
KIRSCHNER, DA
LANSBURY, PT
机构
[1] MIT, DEPT CHEM, CAMBRIDGE, MA 02139 USA
[2] CHILDRENS HOSP MED CTR, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA
关键词
D O I
10.1021/bi00463a003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid 0-protein (1–42) is a major constituent of the abnormal extracellular amyloid plaque that characterizes the brains of victims of Alzheimer’s disease. Two peptides, with sequences derived from the previously unexplored C-terminal region of the 0-protein, 026–33 (H2N-SNKGAIIG-CO2H) and β34-42 (H2N-LMVGGVVIA-CO2H), were synthesized and purified, and their solubility and conformational properties were analyzed. Peptide β26-33 was found to be freely soluble in water; however, peptide β34-42 was virtually insoluble in aqueous media, including 6 M guanidinium thiocyanate. The peptides formed assemblies having distinct fibrillar morphologies and different dimensions as observed by electron microscopy of negatively stained samples. X-ray diffraction revealed that the peptide conformation in the fibrils was cross-β. A correlation between solubility and 0-structure formation was inferred from FTIR studies: β26-33, when dissolved in water, existed as a random coil, whereas the water-insoluble peptide β34-42 possessed antiparallel β-sheet structure in the solid state. Solubilization of β34-42 in organic media resulted in the disappearance of β-structure. These data suggest that the sequence 34–42, by virtue of its ability to form unusually stable β-structure, is a major contributor to the insolubility of the β-protein and may nucleate the formation of the fibrils that constitute amyloid plaque. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:2639 / 2644
页数:6
相关论文
共 49 条
[41]   SOLUBILIZATION OF PEPTIDES IN NON-POLAR ORGANIC-SOLVENTS BY THE ADDITION OF INORGANIC SALTS - FACTS AND IMPLICATIONS [J].
SEEBACH, D ;
THALER, A ;
BECK, AK .
HELVETICA CHIMICA ACTA, 1989, 72 (05) :857-867
[42]   MECHANISMS FOR THE REMOVAL OF BENZYL PROTECTING GROUPS IN SYNTHETIC PEPTIDES BY TRIFLUOROMETHANESULFONIC ACID TRIFLUOROACETIC-ACID DIMETHYL SULFIDE [J].
TAM, JP ;
HEATH, WF ;
MERRIFIELD, RB .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1986, 108 (17) :5242-5251
[43]   3 TYPES OF AMYLOID PROTEIN-PRECURSOR MESSENGER-RNA IN HUMAN-BRAIN - THEIR DIFFERENTIAL EXPRESSION IN ALZHEIMERS-DISEASE [J].
TANAKA, S ;
NAKAMURA, S ;
UEDA, K ;
KAMEYAMA, M ;
SHIOJIRI, S ;
TAKAHASHI, Y ;
KITAGUCHI, N ;
ITO, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (02) :472-479
[44]   INFRARED SPECTROSCOPY OF HUMAN AMYLOID FIBRILS AND IMMUNOGLOBULIN PROTEINS [J].
TERMINE, JD ;
GLENNER, GG ;
EANES, ED ;
EIN, D .
BIOPOLYMERS, 1972, 11 (05) :1103-&
[45]  
TONIOLO C, 1985, 9TH P AM PEPT S, P419
[46]  
VANANDEL ACJ, 1986, AMYLOIDOSIS, P39
[47]   IDENTIFICATION, BIOGENESIS, AND LOCALIZATION OF PRECURSORS OF ALZHEIMERS-DISEASE A4 AMYLOID PROTEIN [J].
WEIDEMANN, A ;
KONIG, G ;
BUNKE, D ;
FISCHER, P ;
SALBAUM, JM ;
MASTERS, CL ;
BEYREUTHER, K .
CELL, 1989, 57 (01) :115-126
[48]   AMYLOID-BETA PROTEIN ENHANCES THE SURVIVAL OF HIPPOCAMPAL-NEURONS INVITRO [J].
WHITSON, JS ;
SELKOE, DJ ;
COTMAN, CW .
SCIENCE, 1989, 243 (4897) :1488-1490
[49]   NEUROTOXICITY OF A FRAGMENT OF THE AMYLOID PRECURSOR ASSOCIATED WITH ALZHEIMERS-DISEASE [J].
YANKNER, BA ;
DAWES, LR ;
FISHER, S ;
VILLAKOMAROFF, L ;
OSTERGRANITE, ML ;
NEVE, RL .
SCIENCE, 1989, 245 (4916) :417-420